| 【公司研究】中国生物制药 (1177 HK) - 创新药收入占比近半，全球化布局提速 |
| 【Company Research】Great Wall Motor (2333 HK/601633 CH) - Possible positive surprise from new platform |
| 【Company Research】GAC Group (2238 HK/601238 CH) - Eyes on Aistaland and exports |
| 【Company Research】Akeso (9926 HK) - Eyes on pivotal ivonescimab readouts |
| 【Company Research】Sinotruk (Hong Kong) (3808 HK) - Export growth outlook more extensive and sustainable; U/G to BUY |
| 【Sector Research】Materials - Supply risks materialized following weekend’s attacks on Middle East aluminium smelters |
| 【Company Research】Innovent Biologics (1801 HK) - Accelerating transition to global biopharma |
| 【Company Research】China Tower (788 HK) - Earnings supported by D&A roll-off while growth remained limited |
| 【Company Research】Baozun (BZUN US) - Heading towards strong medium-term profitability target with solid execution |
| 【Company Research】PATEO CONNECT (2889 HK) - AI pioneer powered by smart cockpit capabilities |
公司地址：香港中環花園道三號冠君大廈45-46樓
電話：（852） 3900-0888 傳真：（852） 3761-8788
招銀國際版權所有 Copyright © 2019-2026 CMB International Capital Corporation Limited. All rights reserved.
